Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST Q4 2025 Annual earnings

Reported November 14, 2025 · Before market open

Revenue$99.0MBeat by $1.6M
EPS-$0.45Beat by $0.05
Revenue estimate$97.4M
EPS estimate-$0.50

Next report

Aug 3, 2026 (In 5 days)
Revenue estimate$114.5M
EPS estimate-$0.50

Financials

Q4 2025

Income statement

See full
Revenue$99.0M+16.9%
Gross profit$50.8M+33.0%
Operating income-$29.9M+16.9%
Net income-$27.1M+21.7%
EPS (diluted)-$0.45+23.7%

Balance sheet

See full
Cash & equivalents$185.4M-19.1%
Total debt$90.6M+6.5%
Total equity$473.0M+0.1%
Total assets$641.9M+4.5%

Cash flow

See full
Operating cash flow-$11.8M+22.9%
CapEx$12.4M+521%
Free cash flow-$24.2M-39.9%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.7B-35.3%
Enterprise value$1.6B-35.4%
P/S4.5×-3.9×

Profitability

See full
Gross margin50.7%+8.1pp
Operating margin-36.2%-11.9pp
Net margin-20.6%-8.4pp
FCF margin-20.1%-1.7pp

Returns & leverage

See full
Return on equity-16.4%-6.0pp
Debt / equity0.2×0.0×
Current ratio3.6×-1.2×

Segments

By geography

See full
Americas$57.3M+8.8%
EMEA$34.6M+35.5%
APAC$7.2M+9.4%

By product

See full
NGS applications$53.0M+16.5%
DNA synthesis and protein solutions$6.4M+21.6%

Versus estimates

Revenue

Q2 2026$110.7MBeat by $3.1MQ1 2026$103.7MBeat by $1.8M
Q4 2025$99.0MBeat by $1.6M
Q3 2025$96.1MMiss by $1.3MQ2 2025$92.8MMiss by $2.6MQ1 2025$88.7MBeat by $1.8M

Diluted EPS

Q2 2026-$0.62Miss by $0.13Q1 2026-$0.50Miss by $0.02
Q4 2025-$0.45Beat by $0.05
Q3 2025-$0.47Beat by $0.07Q2 2025-$0.66Miss by $0.10Q1 2025-$0.53Beat by $0.09

Ask the moment Twist Bioscience Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Twist Bioscience Corporation report Q4 2025 earnings?
Twist Bioscience Corporation (TWST) reported Q4 2025 earnings on November 14, 2025 before market open.
What were Twist Bioscience Corporation's Q4 2025 revenue and EPS?
Twist Bioscience Corporation reported revenue of $99.0M and eps of $-0.45 for Q4 2025.
Did Twist Bioscience Corporation beat estimates in Q4 2025?
Revenue beat the consensus estimate of $97.4M by $1.6M. EPS beat the consensus estimate of $-0.50 by $0.05.
How did Twist Bioscience Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.9% from $84.7M a year earlier and eps grew 23.7% from $-0.59.
Where can I find Twist Bioscience Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001581280-25-000020) and the 10-K periodic report (0001581280-25-000025) directly on SEC EDGAR. The filing index links above go to sec.gov.